fully human mAbs (Valneva/Sanofi Pasteur)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namefully human mAbs (Valneva/Sanofi Pasteur)
Drug Alias Namefully human mAbs (Vivalis/Sanofi Pasteur)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesValneva SE
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVivalis SASanofi Pasteur SaValneva SE
Active IndicationsN/A
Inactive IndicationsCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A